ConductScience.org, home

Paper40599554

Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair.

Nimjee SM and 3 others. Cardiol Plus, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair. Papers, record 40599554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40599554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair.
PubMed
Journal
Cardiol Plus
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-04-04
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nimjee SMShahid M
2de Lange FFellery
3Pitoc GAGeorge A
4Sullenger BABruce A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 HL139420NHLBI NIH HHSUnited StatesP01HL139420PubMed

Source NIH RePORTER

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136296562Not Just Anticoagulation-New and Old Applications of Heparin.Molecules2022https://conductscience.org/library/papers/36296562PubMed
238963354Protamine and Heparin Interactions: A Narrative Review.Ann Card Anaesth2024https://conductscience.org/library/papers/38963354PubMed
316873382Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).Br J Anaesth2006https://conductscience.org/library/papers/16873382PubMed
432417430Pathogenesis of heparin-induced thrombocytopenia.Transl Res2020https://conductscience.org/library/papers/32417430PubMed
510895825Effect of formalin tissue fixation and processing on immunohistochemistry.Am J Surg Pathol2000https://conductscience.org/library/papers/10895825PubMed
638985762An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38985762PubMed
716765093A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.Mol Ther2006https://conductscience.org/library/papers/16765093PubMed
839200826Management of Heparin-Induced Thrombocytopenia: A Contemporary Review.J Clin Med2024https://conductscience.org/library/papers/39200826PubMed
912214238RNA aptamers as reversible antagonists of coagulation factor IXa.Nature2002https://conductscience.org/library/papers/12214238PubMed
1015660527Aptamers: an emerging class of therapeutics.Annu Rev Med2005https://conductscience.org/library/papers/15660527PubMed
1139725085Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia.J Thromb Haemost2025https://conductscience.org/library/papers/39725085PubMed
1215795162The potential of aptamers as anticoagulants.Trends Cardiovasc Med2005https://conductscience.org/library/papers/15795162PubMed
1315681944Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery.Anesthesiology2005https://conductscience.org/library/papers/15681944PubMed
1416308000Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.J Thorac Cardiovasc Surg2005https://conductscience.org/library/papers/16308000PubMed
1511775016Myocardial contraction bands. Definition, quantification and significance in forensic pathology.Int J Legal Med2001https://conductscience.org/library/papers/11775016PubMed
168694611Direct and interactive effects of cardioplegic arrest and protamine on myocyte contractility.Ann Thorac Surg1996https://conductscience.org/library/papers/8694611PubMed
1725065530Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.Chem Biol2014https://conductscience.org/library/papers/25065530PubMed
1828644959Generation and characterization of aptamers targeting factor XIa.Thromb Res2017https://conductscience.org/library/papers/28644959PubMed
1935927191Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery.J Cardiothorac Vasc Anesth2022https://conductscience.org/library/papers/35927191PubMed
2020022942An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.J Biol Chem2010https://conductscience.org/library/papers/20022942PubMed

See all 47 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40599554

GET https://conductscience.org/api/papers/v1/40599554/references?page=2